Back
Benitec Biopharma, Inc. 10K Form
Sell
44
BNTC
Benitec Biopharma, Inc.
Last Price:
$13.36
Seasonality Move:
8.41%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-13 | 10Q | BNTC/Benitec Biopharma, Inc. Quarterly |
| 2023-05-15 | 10Q | BNTC/Benitec Biopharma, Inc. Quarterly |
| 2023-02-13 | 10Q | BNTC/Benitec Biopharma, Inc. Quarterly |
| 2022-11-10 | 10Q | BNTC/Benitec Biopharma, Inc. Quarterly |
| 2022-05-16 | 10Q | BNTC/Benitec Biopharma, Inc. Quarterly |
| 2022-02-14 | 10Q | BNTC/Benitec Biopharma, Inc. Quarterly |
Receive BNTC News And Ratings
See the #1 stock for the next 7 days that we like better than BNTC
BNTC Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-3.4M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.57 |
| Price / Book: | 4.77 |
Profitability
| EPS (TTM): | -1.00540 |
|---|---|
| Net Income (TTM): | $-34.5M |
| Gross Margin: | $-396K |
| Return on Equity: | -40.23% |
| Return on Assets: | -38.43% |
Benitec Biopharma, Inc. Earnings Forecast
Key Benitec Biopharma, Inc. Financial Ratios
-
Per Share Earnings over the last 30 years have been positive in 19 years.
Benitec Biopharma, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BNTC |
| CUSIP: | 08205P |
| Website: | benitec.com |
Debt
| Debt-to-Equity Ratio: | 0.01 |
|---|---|
| Current Ratio: | 46.95 |
| Quick Ratio: | 46.72 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BNTC Technical Analysis vs Fundamental Analysis
Sell
44
Benitec Biopharma, Inc. (BNTC)
is a Sell
Is Benitec Biopharma, Inc. a Buy or a Sell?
-
Benitec Biopharma, Inc. stock is rated a SellThe current Benitec Biopharma, Inc. [BNTC] share price is $13.18. The Score for BNTC is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.